Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL325215 | 0.95 | HCAR2 (0.54) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL10347496 | 0.94 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL6060612 | 0.94 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL121143 | 0.94 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL9299634 | 0.94 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL7739132 | 0.93 | TSHR (0.54) | HCAR2ATMTSHRHPGDALDH1A1 | |
| Acrolein SCHEMBL11765426 | 0.93 | HCAR2 (0.46) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL18171852 | 0.91 | HCAR2 (0.44) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL7129943 | 0.90 | TSHR (0.48) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL10940121 | 0.90 | TSHR (0.51) | HCAR2ATMTSHRHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063844-A | Polymer product, preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | XEROX CORPORATION (US) | 2018-10-30 | — | — | US | claimed |
| US-10067434-B2 | Emulsion aggregation toners | XEROX CORPORATION (US) | 2018-09-04 | — | — | US | claimed |
| US-10018930-B2 | Toner comprising colorant wax dispersion | XEROX CORPORATION (US) | 2018-07-10 | — | — | US | claimed |
| US-10018931-B2 | Toner compositions with optimized beta-carboxyethyl acrylate shell latex for improved particle formation and morphology | XEROX CORPORATION (US) | 2018-07-10 | — | — | US | claimed |
| US-10007200-B2 | Antimicrobial toner | XEROX CORPORATION (US) | 2018-06-26 | — | — | US | claimed |
| US-20060286478-A1 | Toner processes | XEROX CORPORATION | 2006-12-21 | — | — | US | claimed |
| US-20060154162-A1 | Toner particles and methods of preparing the same | XEROX CORPORATION (US) | 2006-07-13 | — | — | US | claimed |
| US-5928829-A | Latex processes | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| US-5858601-A | Toner processes | XEROX CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| EP-0851012-A2 | Ink jet inks containing linear polymer additives | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-07-01 | — | — | EP | claimed |
| US-5763133-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-06-09 | — | — | US | claimed |
| US-5747215-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
| US-5602197-A | CONSISTS OF LOW MELTING WAX SELECTED FORM FATTY ACID, ALCOHOL, GLYCOL, GLYCERIDE AND ESTER, HIGH MOLECULAR WEIGHT HOMO OR COPOLYMERS, COMPOUNDED WITH CERAMIC POWDER | CORNING INCORPORATED (US) | 1997-02-11 | — | — | US | claimed |
| EP-0400778-B1 | Reversible polymer gel binders for powder forming | CORNING INC (US) | 1994-11-02 | — | — | EP | claimed |
| EP-0400778-A2 | Reversible polymer gel binders for powder forming | Corning Incorporated (US) | 1990-12-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | RPN1, RPN2, MSH2 | HCAR2 4553/4885ATM 1068/4885TSHR 4205/4885 |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | HCAR2 4392/4885ATM 1939/4885TSHR 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.